Home/Filings/4/0000875320-25-000014
4//SEC Filing

Biller Jonathan 4

Accession 0000875320-25-000014

CIK 0000875320other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:32 PM ET

Size

4.9 KB

Accession

0000875320-25-000014

Insider Transaction Report

Form 4
Period: 2025-02-04
Biller Jonathan
EVP and Chief Legal Officer
Transactions
  • Award

    Common Stock

    2025-02-04+4,74421,395 total
Footnotes (1)
  • [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001744749

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:32 PM ET
Size
4.9 KB